ANGLE plc (OTCMKTS:ANPCY) Short Interest Update

by · The Cerbat Gem

ANGLE plc (OTCMKTS:ANPCYGet Free Report) was the target of a significant drop in short interest in December. As of December 15th, there was short interest totaling 2,799 shares, a drop of 94.5% from the November 30th total of 50,523 shares. Based on an average daily trading volume, of 28,223 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily trading volume, of 28,223 shares, the days-to-cover ratio is presently 0.1 days.

ANGLE Stock Down 0.3%

Shares of ANPCY stock traded down C$0.00 on Wednesday, reaching C$0.07. The company had a trading volume of 539 shares, compared to its average volume of 11,314. The business’s 50-day moving average is C$0.19 and its 200 day moving average is C$0.52. ANGLE has a one year low of C$0.07 and a one year high of C$2.39.

ANGLE Company Profile

(Get Free Report)

ANGLE plc is a United Kingdom–based biotechnology company specializing in the development and commercialization of liquid biopsy technologies for the capture and analysis of rare cells. The company’s principal offering, the Parsortix system, employs proprietary microfluidic instrumentation to isolate circulating tumor cells (CTCs) and other rare cell populations from blood samples without the need for labels. This platform is designed for both research and clinical applications, enabling downstream molecular and cellular analyses that support cancer diagnostics, prognostics and therapy monitoring.

ANGLE’s product portfolio comprises the Parsortix Harvest system and single-use cassettes, along with associated reagents and software for cell capture, imaging and data management.

See Also